Physician profile
Noelle C Digioia Guthrie
NPI 1073053419
$14,520.70
in general payments reported to CMS, 2019-2025
7 companies · $3,728 in 2025
The $3,728 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $828 · 2021: $1,322 · 2022: $430 · 2023: $429 · 2024: $7,784 · 2025: $3,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,188 · Travel and Lodging: $1,499 · Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,187.50 |
| Travel and Lodging | $1,498.96 |
| Food and Beverage | $1,254.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,850.27 | 2022-2025 | Journey II, Real Intelligence, Hip7 |
| Liberty Surgical INC. | $2,028.00 | 2020-2021 | |
| Depuy Synthes Sales INC. | $237.21 | 2023 | |
| Medical Device Business Services, INC. | $127.51 | 2023 | Attune, Actis |
| Vericel Corporation | $121.70 | 2021 | |
| Stryker Corporation | $118.76 | 2022 | |
| Acumed LLC | $37.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noelle Digioia Guthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.